| related words |
| medimmune |
| ipilimumab |
| biosensors |
| neuropathic |
| apap |
| outlicensing |
| pediatric |
| sanctura |
| arcalyst |
| abthrax |
| levoleucovorin |
| analyzer |
| carcinogenicity |
| advexin |
| finishing |
| synthesis |
| bioequivalence |
| preapproval |
| norcross |
| ppi |
|
| related documents |
| 1444570--12/17/2010--Axcan_Intermediate_Holdings_Inc. |
| 1159036--3/12/2010--HALOZYME_THERAPEUTICS_INC |
| 1049210--3/16/2007--DIVERSA_CORP |
|
| related topics |
| {product, candidate, development} |
| {regulation, government, change} |
| {provision, law, control} |
| {property, intellectual, protect} |
| {financial, litigation, operation} |
| {control, financial, internal} |
| {operation, natural, condition} |
| {product, liability, claim} |
| {loan, real, estate} |
| {stock, price, operating} |
| {condition, economic, financial} |
| {product, market, service} |
| {interest, director, officer} |
| {acquisition, growth, future} |
| {loss, insurance, financial} |
| {competitive, industry, competition} |
| {customer, product, revenue} |
| {gas, price, oil} |
| {investment, property, distribution} |
| {cost, regulation, environmental} |
|